Know Cancer

or
forgot password

Biomarkers in Exhaled Breath (Condensate) Indicate Presence, Severity and Control of Asthma


N/A
5 Years
18 Years
Not Enrolling
Both
Asthma, Healthy, Children

Thank you

Trial Information

Biomarkers in Exhaled Breath (Condensate) Indicate Presence, Severity and Control of Asthma


Inclusion Criteria:



- Asthmatic and control children, aged 5 to 16 years

- Children with doctor-diagnosed asthma, known at the department of Paediatric
Pulmonology, University Hospital Maastricht

Exclusion Criteria:

- Presence of a disease that might interfere with the results of this study (e.g.
recent upper airway infection, heart disease, anatomic abnormalities of the airways
and other chronic inflammatory diseases such as Crohns disease and rheumatoid
arthritis)

- Mental retardation

- Inability to perform the EBC procedure properly

- Active smoking

- The use of one of the following medication: Papaverin, Sodium nitroprusside, ACE
inhibitors, Oxymetazoline, L-arginine, or NOS inhibitors

Type of Study:

Observational

Study Design:

Allocation: Random Sample, Primary Purpose: Screening, Time Perspective: Cross-Sectional, Time Perspective: Prospective

Principal Investigator

Charlotte M Robroeks, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Maastricht University Medical Center

Authority:

Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Study ID:

MEC 03-228

NCT ID:

NCT00404976

Start Date:

June 2004

Completion Date:

April 2005

Related Keywords:

  • Asthma
  • Healthy
  • Children
  • inflammometry
  • exhaled breath condensate
  • fractional exhaled nitric oxide
  • asthma
  • children
  • Asthma

Name

Location